期刊文献+

化瘀消症散结法对EMA异位内膜MMP-2、MMP-7表达影响的研究 被引量:1

下载PDF
导出
摘要 目的:探讨化瘀消症散结法—莪棱胶囊治疗卵巢子宫内膜异位囊肿抑制异位内膜侵袭性的作用机理,为临床应用提供依据。方法:前瞻性地观察莪棱胶囊治疗卵巢子宫内膜异位囊肿对异位内膜MMP-2、MMP-7表达的影响,探讨莪棱胶囊抑制异位内膜侵袭性的治疗作用机理。收集2002~2004年因卵巢子宫内膜异位囊肿于广东省中医院妇科住院行手术治疗的患者60例。随机分为两组:中药治疗组术前应用莪棱胶囊治疗3个月,6粒/次,每日3次,行保守手术治疗。对照组术前不用药,行保守手术治疗。术中采取异位内膜组织,应用免疫组化方法检测MMP-2、MMP-7表达。结果:中药组MMP-2和MMP-7的表达明显低于对照组,P〈0.05。结论:中药莪棱胶囊应用能明显降低异位内膜组织MMP-2和MMP-7的含量,从而可能通过抑制异位内膜组织的侵袭能力达到治疗目的。
出处 《中成药》 CAS CSCD 北大核心 2008年第2期173-175,共3页 Chinese Traditional Patent Medicine
基金 中国博士后基金资助项目(批准号:2003033408) 广东省自然基金项目(批准号:04300395)
  • 相关文献

参考文献4

  • 1中华人民共和国卫生部制定发布.中药新药临床研究指导原则[S].,1993.215—218.
  • 2来佩琍.妇产科疾病诊断标准[M].北京:科学出版社,2001:287-299.
  • 3齐璇,辛晓燕,常吉庆,王德堂,郭会玲.基质金属蛋白酶-2在子宫内膜异位症与子宫腺肌症中的表达及其意义[J].中国综合临床,2002,18(12):1130-1131. 被引量:2
  • 4Mori T,Yamasaki S, Masui F,et al. Suppression of the development of experimentally induced uterine adenomyosis by a novel matrix metalloproteinase inhibitor ONO-4817 in mice [J].Exp Biol Med (Maywood) ,2001,226 (5) :429-433.

二级参考文献11

  • 1Bruner Tran KL,Rier SE,Eisenberg E,et al.The potential role of envir onmental toxins in the pathophysiology of endometriosis.Gynecol Obstet Invest,19 99,48(1):45-46
  • 2Sampson J.Peritoneal endometriosis due to mentraldissemination o f e ndometrial tissue into the peritoneal cavity.Am J Obster Gnecol,1997,14(7):422- 469
  • 3Sillem M,Hahn U,Coddington CC,et al.Ectopic growth ofendometrium d e pends on its structural integrity and proteolytic activity in the cynomolgus mon key (Macaca fascicularis) model of endometriosis.Fertil Steril,1996,66(3):468-4 773
  • 4Regidor PA,Vogel C,Regidodr M,et al. Expression pattern of intergrin adhesion molecules in endometriosis and human endometrium.Hum Reprod Update,199 8,4(2):710-718
  • 5Boyd RS,Balkwill FR.MMP-2 release and activation in ovarian carcino ma:the role of fibroblasts.Br J Cancer,1999,80(5):315-321
  • 6Bruner KL,Matrisian LM,Rodgers WH,et al.Suppression ofmatrix met all oproteinases inhibits establishment of ectopic lesions by human endometrium in n ude mice.J Clin Invest,1997,99(12):2851-2857
  • 7Wenzl RJ,Heinzl H.Localization of matrix metalloproteinase-2 in ute rine endometrium and ectopic implants.Gynecol Obstet Invest,1998,45(3):253-257
  • 8Ries C,Petrides PE,Cytokine regulation of matrix metallop-roteina ses activity and is regulatory dysfunction in disease.Biol Chem,1995,376(9):345-35 5
  • 9Rawdanowicy T,Hampton A.Matrix metalloproteinaseprod u ction by cultured human endometrial cells:identification of interstitial collage nase,gelatinase-A,gelatinase-B,and stromelysin-1 and tumor necrosis factor-2 .J Chin Endo Metab,1994,79(2):530-536
  • 10Bruner KL,Eisenberg E,Grostein F,et al.Progesterone andtra nsforming growth factor-beta coordinately regulate suppression of endometrial m atrix metalloproteinases in a model of experimental endometriosisi.Steroids,1999 ,64(9):648-653

共引文献15

同被引文献28

引证文献1

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部